Reporting owner · Q3 2026 · CIK 1650527

Green Jeremy: insider trades.

Green Jeremy reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10.2M) and 0 sales, across 2 companies.

Transactions
5
Purchases (P)
2
Sales (S)
0
Companies
2
Name as filed
Green Jeremy

Companies

CompanyRelationshipTransactions
Attovia Therapeutics, Inc. (ATTO)TenPercentOwner3
Atara Biotherapeutics, Inc. (ATRA)Director2

Transactions

5 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-06Attovia Therapeutics, Inc.P200,000$17982,854Form 4
2026-08-06Attovia Therapeutics, Inc.C782,854—782,854Form 4
2026-08-06Attovia Therapeutics, Inc.P400,000$171,182,854Form 4
2026-07-22Atara Biotherapeutics, Inc.F60—636,852Form 4
2026-07-22Atara Biotherapeutics, Inc.M195,211—636,912Form 4

Questions

What stock did Green Jeremy buy or sell?

Green Jeremy reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 2 open-market purchases ($10.2M) and 0 sales, across 2 companies.

Is Green Jeremy the same person as other filers with this name?

This page covers SEC CIK 1650527 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/green-jeremy-1650527.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.